Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia

Erstveröffentlichung
2019Authors
Ottmann, Oliver G.
Mueller-Tidow, Carsten
Kraemer, Alwin
Schlenk, Richard Friedrich
Luebbert, Michael
Wissenschaftlicher Artikel
Published in
British Journal of Haematology ; 184 (2019), 6. - S. 1017-1020. - ISSN 0007-1048. - eISSN 1365-2141